| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |